This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Scott Collins - Innovator in Cancer Treatment
Introduction
Scott Collins is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on antibody drug conjugates. With a total of 2 patents, Collins is recognized for his dedication to advancing medical science.
Latest Patents
Collins' latest patents focus on anti-CDH6 antibody drug conjugates. The present invention relates to anti-CDH6 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer. This groundbreaking work aims to improve therapeutic options for patients battling this disease.
Career Highlights
Scott Collins is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to the development of innovative treatments.
Collaborations
Some of his notable coworkers include Carl Uli Bialucha and Clemens Dürr. Their combined expertise enhances the research and development efforts at Novartis AG.
Conclusion
Scott Collins is a prominent figure in the realm of cancer treatment innovations. His work on anti-CDH6 antibody drug conjugates exemplifies his commitment to improving patient outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile